Natixis Advisors LLC Purchases Shares of 36,115 Oscar Health, Inc. (NYSE:OSCR)

Natixis Advisors LLC acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 36,115 shares of the company’s stock, valued at approximately $485,000.

A number of other large investors have also made changes to their positions in the stock. Hennessy Advisors Inc. lifted its position in Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after purchasing an additional 3,544,300 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Oscar Health by 68.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after buying an additional 938,742 shares in the last quarter. Soros Fund Management LLC bought a new position in shares of Oscar Health during the 3rd quarter worth about $12,726,000. Raymond James Financial Inc. acquired a new stake in shares of Oscar Health during the 4th quarter valued at about $6,613,000. Finally, Amundi increased its stake in Oscar Health by 232.3% in the fourth quarter. Amundi now owns 690,654 shares of the company’s stock valued at $9,282,000 after acquiring an additional 482,784 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Down 2.3 %

NYSE OSCR opened at $13.45 on Friday. The stock’s 50 day simple moving average is $14.96 and its 200 day simple moving average is $16.12. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79. The firm has a market cap of $3.37 billion, a PE ratio of -672.01 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on OSCR. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Oscar Health presently has a consensus rating of “Hold” and a consensus target price of $20.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.